Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06506903 · ClinicalTrials.gov registry record · NA

Avalus Ultra Post-Approval Study (PAS)

A NA study of Aortic Valve Disease, sponsored by Medtronic Cardiac Surgery.

Active
Registry status
NA
Development phase
190
Enrollment target
15
Study locations

NCT06506903 is a NA study of Aortic Valve Disease that is active but no longer recruiting, run by Medtronic Cardiac Surgery. The registered enrollment target is 190 participants, below the 18,604-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The trial reports 15 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06506903, a NA study of Aortic Valve Disease, is active but no longer recruiting, sponsored by Medtronic Cardiac Surgery.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
190 participants
Enrollment target
15
Study locations

Study Summary

The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.

Conditions Studied

Aortic Valve Disease

Interventions

  • DEVICE Medtronic Avalus Ultra

Study Locations (15)

Texas

  • Heart Hospital of Austin - Austin
  • CHI Saint Lukes Health - Baylor Saint Lukes Medical Center - Houston
  • Houston Methodist Hospital - Houston

Georgia

  • Emory Saint Joseph's - Atlanta
  • WellStar Kennestone Hospital - Marietta

Ohio

  • UH Cleveland Medical Center - Cleveland
  • ProMedica Toledo Hospital - Toledo

Connecticut

  • Hartford Hospital - Hartford

Florida

  • University of Florida Shands - Gainesville

Illinois

  • Northwestern Memorial Hospital - Chicago

Michigan

  • University of Michigan Health System - University Hospital - Ann Arbor

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2024-11-20
Est. Completion 2026-11
Phase NA

Sponsor

Medtronic Cardiac Surgery

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06506903

The ClinicalTrials.gov registry entry for NCT06506903 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 18,604-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The listed sponsor is Medtronic Cardiac Surgery, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aortic Valve Disease appearing as the primary indexed condition, and to 1 intervention - of which Medtronic Avalus Ultra is the first listed.

NCT06506903 reports 15 study locations spanning 11 distinct geographic areas - top geographies include Texas, Georgia, Ohio.

Frequently Asked Questions

What is clinical trial NCT06506903 about?

NCT06506903 is a clinical study titled "Avalus Ultra Post-Approval Study (PAS)". The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.

What is the current status of trial NCT06506903?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2024-11-20. Estimated completion is 2026-11.

What conditions does trial NCT06506903 study?

This clinical trial studies the following conditions: Aortic Valve Disease.

What interventions are being tested in trial NCT06506903?

The interventions under investigation include: Medtronic Avalus Ultra (DEVICE).

Who is sponsoring clinical trial NCT06506903?

This trial is sponsored by Medtronic Cardiac Surgery, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06506903 being conducted?

This trial has 15 study locations across Connecticut, Florida, Georgia, Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aortic Valve Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Aortic Valve Disease

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.